Effects on birth weight and perinatal mortality of maternal dietary supplements in rural gambia: 5 year randomised controlled trial

BMJ
Sep 1997
Citations:443
Influential Citations:28
Interventional (Human) Studies
81
High RoB
S2 IconPDF Icon

Enhanced Details

Methods
Design: prospective randomized controlled trial in rural Gambia (West Kiang). Participants: pregnant women aged 15–45 years, chronically undernourished; singleton pregnancies; 28 villages randomized to intervention or control; 1460 women contributed births; 2047 singleton live births and 35 stillbirths used for mortality analyses; recruitment 1989–1994; routine antenatal care; ethical approval.
Intervention
Two biscuits per day starting around 20 weeks' gestation and continuing to term, providing about 4250 kJ energy, 22 g protein, 56 g fat, 47 mg calcium, and 1.8 mg iron per day.
Results
Conclusion: Prenatal dietary supplementation reduced intrauterine growth retardation when targeted at genuinely at-risk mothers, and was associated with substantial reductions in stillbirths and early neonatal mortality. Mean birth weight rose by 136 g overall (201 g during hungry season June–October; 94 g during harvest season November–May); low birthweight fell from 17.0% to 11.1% (OR 0.61). Head circumference increased by 3.1 mm; birth length and gestational age unchanged. Stillbirths (OR 0.47), perinatal deaths (0.54), and deaths within 28 days postpartum (0.57) declined; neonatal mortality excluding stillbirths did not reach significance (OR 0.64). The intervention is feasible via primary healthcare; greatest benefit occurs when targeted to late-pregnancy, nutritionally deprived populations.
Limitations
Missing Parkin scores for some births and uncertain parity; some data unavailable for unadjusted analyses; hungry-season classification defined post hoc; cause-of-death data not available in field setting.

Abstract

Abstract Objective: To test the efficacy in terms of birth weight and infant survival of a diet supplement programme in pregnant African women through a primary healthcare system. Design: 5 year controlled trial of all pregnant women in 28 villages r...